Class II, which currently consists of four (4) members, Robert Hartman, Joshua Hausman, James V. McKeon and David Reis, has a term expiring at the close of our 2016 annual meeting of stockholders. Class III, which currently consists of four (4) members, James H. Bloem, John F. DePodesta, Steven Fishman and Glenn S. Schafer, has a term expiring at the close of our 2017 annual meeting of stockholders. We do not currently have any vacancies on our board of directors.
Mr. Hausman is a Managing Director of Onex Corporation and is actively involved in Onex Corporation’s healthcare investment activities.
Mr. Hausman has been with Onex Corporation since 2004 and has served in his current role as Managing Director since January 2013.
Prior to joining Onex Corporation, Mr. Hausman worked in the investment banking division of Banc of America Securities LLC as part of the healthcare group.
Mr. Hausman has previously served as a director and Chairman of the Audit Committee for the Center for Diagnostic Imaging.
Based upon Mr. Hausman’s extensive experience with healthcare companies, his experience in finance and auditing and his significant beneficial ownership in the company’s stock, as described below in “Security Ownership of Directors and Executive Officers and Certain Beneficial Owners,” the board of directors has concluded that he should serve as a director.
Bloem, DePodesta, Fishman, Hager, Hartman, Hausman
, McKeon, Reis and Whitman to fill the resulting vacancies in the applicable classes of directors (as noted in the table above).
Bloem, DePodesta, Hausman and Schafer is an independent member of our board of directors under the applicable listing standards of the NYSE.